-
Kapinas K, Grandy R, Ghule P, Medina R, Becker K, Pardee A, Zaidi SK, Lian J, Stein J, van Wijnen A, Stein G. The abbreviated pluripotent cell cycle. J Cell Physiol. 2013 Jan; 228(1):9-20.
-
Qiao M, Shi Q, Pardee AB. The pursuit of oncotargets through understanding defective cell regulation. Oncotarget. 2010 Nov; 1(7):544-51.
-
Martin KJ, Fournier MV, Reddy GP, Pardee AB. A need for basic research on fluid-based early detection biomarkers. Cancer Res. 2010 Jul 1; 70(13):5203-6.
-
Qiao M, Wang Y, Xu X, Lu J, Dong Y, Tao W, Stein J, Stein GS, Iglehart JD, Shi Q, Pardee AB. Mst1 is an interacting protein that mediates PHLPPs' induced apoptosis. Mol Cell. 2010 May 28; 38(4):512-23.
-
Sheng S, Qiao M, Pardee AB. Metastasis and AKT activation. J Cell Physiol. 2009 Mar; 218(3):451-4.
-
Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle. 2008 Oct; 7(19):2991-6.
-
Pardee AB, Qiao M. A devious cube of cancer. J Cell Physiol. 2008 Jul; 216(1):1-2.
-
Qiao M, Pardee AB. Biomarkers, regerons, and pathways to lethal cancer. J Cell Biochem. 2007 Dec 1; 102(5):1076-86.
-
Singh S, Shi Q, Bailey ST, Palczewski MJ, Pardee AB, Iglehart JD, Biswas DK. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Mol Cancer Ther. 2007 Jul; 6(7):1973-82.
-
Qiao M, Iglehart JD, Pardee AB. Metastatic potential of 21T human breast cancer cells depends on Akt/protein kinase B activation. Cancer Res. 2007 Jun 1; 67(11):5293-9.
-
Bai VU, Kaseb A, Tejwani S, Divine GW, Barrack ER, Menon M, Pardee AB, Reddy GP. Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine. Proc Natl Acad Sci U S A. 2007 Feb 13; 104(7):2343-8.
-
Liang P, Meade JD, Pardee AB. A protocol for differential display of mRNA expression using either fluorescent or radioactive labeling. Nat Protoc. 2007; 2(3):457-70.
-
Pardee AB. Tumor progression--targets for differential therapy. J Cell Physiol. 2006 Dec; 209(3):589-91.
-
Monks NR, Pardee AB. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. J Cell Biochem. 2006 May 1; 98(1):221-33.
-
Pardee AB. Regulatory molecular biology. Cell Cycle. 2006 Apr; 5(8):846-52.
-
Wang A, Li CJ, Reddy PV, Pardee AB. Cancer chemotherapy by deoxynucleotide depletion and E2F-1 elevation. Cancer Res. 2005 Sep 1; 65(17):7809-14.
-
Biswas DK, Singh S, Shi Q, Pardee AB, Iglehart JD. Crossroads of estrogen receptor and NF-kappaB signaling. Sci STKE. 2005 Jun 14; 2005(288):pe27.
-
Pardee AB, Li CJ, Reddy GP. Regulation in S phase by E2F. Cell Cycle. 2004 Sep; 3(9):1091-4.
-
Monks NR, Biswas DK, Pardee AB. Blocking anti-apoptosis as a strategy for cancer chemotherapy: NF-kappaB as a target. J Cell Biochem. 2004 Jul 1; 92(4):646-50.
-
Biswas DK, Shi Q, Baily S, Strickland I, Ghosh S, Pardee AB, Iglehart JD. NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A. 2004 Jul 6; 101(27):10137-42.
-
Pardee AB. Rambling thoughts about doing and thinking research. Cancer Biol Ther. 2004 Jun; 3(6):573-7.
-
Pardee AB, Reddy GP. Beginnings of feedback inhibition, allostery, and multi-protein complexes. Gene. 2003 Dec 4; 321:17-23.
-
Liang P, Pardee AB. Analysing differential gene expression in cancer. Nat Rev Cancer. 2003 Nov; 3(11):869-76.
-
Pardee AB. Normal cells arrest cancer cells in G2. Cell Cycle. 2003 Sep-Oct; 2(5):454.
-
Goodman AB, Pardee AB. Evidence for defective retinoid transport and function in late onset Alzheimer's disease. Proc Natl Acad Sci U S A. 2003 Mar 4; 100(5):2901-5.
-
Li Y, Sun X, LaMont JT, Pardee AB, Li CJ. Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer. Proc Natl Acad Sci U S A. 2003 Mar 4; 100(5):2674-8.
-
Biswas DK, Martin KJ, McAlister C, Cruz AP, Graner E, Dai SC, Pardee AB. Apoptosis caused by chemotherapeutic inhibition of nuclear factor-kappaB activation. Cancer Res. 2003 Jan 15; 63(2):290-5.
-
Keyomarsi K, Pardee AB. Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents. Prog Cell Cycle Res. 2003; 5:527-32.
-
Fournier MV, Martin KJ, Graner E, Pardee AB. Sensitive assays for detection of lung cancer. Molecular markers in blood samples. Methods Mol Med. 2003; 75:239-50.
-
Pardee AB. PaJaMas in Paris. Trends Genet. 2002 Nov; 18(11):585-7.
-
Pardee AB, Li YZ, Li CJ. Cancer therapy with beta-lapachone. Curr Cancer Drug Targets. 2002 Sep; 2(3):227-42.
-
Pardee AB. Role reversal for anticancer agents. Cancer Biol Ther. 2002 Jul-Aug; 1(4):426-7.
-
Pardee AB. Regulation, restriction, and reminiscences. J Biol Chem. 2002 Jul 26; 277(30):26709-16.
-
Blagosklonny MV, Pardee AB. Conceptual biology: unearthing the gems. Nature. 2002 Mar 28; 416(6879):373.
-
Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle. 2002 Mar-Apr; 1(2):103-10.
-
Liang P, Pardee AB. Differential display of mRNA by PCR. Curr Protoc Mol Biol. 2001 Nov; Chapter 25:Unit 25B.3.
-
Geng Y, Yu Q, Whoriskey W, Dick F, Tsai KY, Ford HL, Biswas DK, Pardee AB, Amati B, Jacks T, Richardson A, Dyson N, Sicinski P. Expression of cyclins E1 and E2 during mouse development and in neoplasia. Proc Natl Acad Sci U S A. 2001 Nov 6; 98(23):13138-43.
-
Biswas DK, Dai SC, Cruz A, Weiser B, Graner E, Pardee AB. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers. Proc Natl Acad Sci U S A. 2001 Aug 28; 98(18):10386-91.
-
Blagosklonny MV, Pardee AB. Exploiting cancer cell cycling for selective protection of normal cells. Cancer Res. 2001 Jun 1; 61(11):4301-5.
-
Martin KJ, Graner E, Li Y, Price LM, Kritzman BM, Fournier MV, Rhei E, Pardee AB. High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2646-51.
-
Biswas DK, Cruz A, Pettit N, Mutter GL, Pardee AB. A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. Mol Med. 2001 Jan; 7(1):59-67.
-
Fournier MV, Martin KJ, Pardee AB. Solid tumor cancer markers and applications to steroid hormone research. Methods Mol Biol. 2001; 176:329-40.
-
Pardee AB. Ruth Sager. Biogr Mem Natl Acad Sci. 2001; 80:276-89.
-
Li Y, Li CJ, Yu D, Pardee AB. Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells. Mol Med. 2000 Dec; 6(12):1008-15.
-
Huang L, Sowa Y, Sakai T, Pardee AB. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Oncogene. 2000 Nov 23; 19(50):5712-9.
-
Biswas DK, Cruz AP, Pardee AB. Detection of the level of estrogen receptor and functional variants in human breast cancers by novel assays. Biotechniques. 2000 Nov; 29(5):1056-60, 1062-4.
-
Huang L, Pardee AB. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med. 2000 Oct; 6(10):849-66.
-
Goodman AB, Pardee AB. Meeting report; "Molecular neurobiological mechanisms in schizophrenia: seeking a synthesis," April 11-14, 1999. Biol Psychiatry. 2000 Aug 1; 48(3):173-83.
-
Ford HL, Landesman-Bollag E, Dacwag CS, Stukenberg PT, Pardee AB, Seldin DC. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J Biol Chem. 2000 Jul 21; 275(29):22245-54.
-
Biswas DK, Cruz AP, Gansberger E, Pardee AB. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A. 2000 Jul 18; 97(15):8542-7.
-
Martin KJ, Kritzman BM, Price LM, Koh B, Kwan CP, Zhang X, Mackay A, O'Hare MJ, Kaelin CM, Mutter GL, Pardee AB, Sager R. Linking gene expression patterns to therapeutic groups in breast cancer. Cancer Res. 2000 Apr 15; 60(8):2232-8.
-
Martin KJ, Pardee AB. Identifying expressed genes. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):3789-91.
-
Bosch I, Melichar H, Pardee AB. Identification of differentially expressed genes from limited amounts of RNA. Nucleic Acids Res. 2000 Apr 1; 28(7):E27.
-
Guan RJ, Ford HL, Fu Y, Li Y, Shaw LM, Pardee AB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 2000 Feb 1; 60(3):749-55.
-
Melichar H, Bosch I, Molnar GM, Huang L, Pardee AB. Detection of eukaryotic cDNA in differential display is enhanced by the addition of E. coli RNA. Biotechniques. 2000 Jan; 28(1):76-82.
-
Li CJ, Li YZ, Pinto AV, Pardee AB. Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: combining drugs imposes different artificial checkpoints. Proc Natl Acad Sci U S A. 1999 Nov 9; 96(23):13369-74.
-
Huang L, Pardee AB. beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells. Mol Med. 1999 Nov; 5(11):711-20.
-
Cohen SS, Li C, Ding L, Cao Y, Pardee AB, Shevach EM, Cohen DI. Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci U S A. 1999 Sep 14; 96(19):10842-7.
-
Fournier MV, Guimarães da Costa F, Paschoal ME, Ronco LV, Carvalho MG, Pardee AB, Giumaraes FC. Identification of a gene encoding a human oxysterol-binding protein-homologue: a potential general molecular marker for blood dissemination of solid tumors. Cancer Res. 1999 Aug 1; 59(15):3748-53.
-
Guan RJ, Fu Y, Holt PR, Pardee AB. Association of K-ras mutations with p16 methylation in human colon cancer. Gastroenterology. 1999 May; 116(5):1063-71.
-
Fournier MV, Carvalho MG, Pardee AB. A strategy to identify genes associated with circulating solid tumor cell survival in peripheral blood. Mol Med. 1999 May; 5(5):313-9.
-
Li YZ, Li CJ, Pinto AV, Pardee AB. Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells. Mol Med. 1999 Apr; 5(4):232-9.
-
Huang L, Guan RJ, Pardee AB. Evolution of transcriptional control from prokaryotic beginnings to eukaryotic complexities. Crit Rev Eukaryot Gene Expr. 1999; 9(3-4):175-82.
-
Ford HL, Pardee AB. Cancer and the cell cycle. J Cell Biochem. 1999; Suppl 32-33:166-72.
-
Martin KJ, Pardee AB. Principles of differential display. Methods Enzymol. 1999; 303:234-58.
-
Biswas DK, Reddy PV, Pickard M, Makkad B, Pettit N, Pardee AB. Calmodulin is essential for estrogen receptor interaction with its motif and activation of responsive promoter. J Biol Chem. 1998 Dec 11; 273(50):33817-24.
-
Liang P, Pardee AB. Differential display. A general protocol. Mol Biotechnol. 1998 Dec; 10(3):261-7.
-
Borodyansky L, Li YZ, Pardee AB, Li CJ. Apoptosis in non-proliferating cells: implications for viral infection and tumourigenesis. Apoptosis. 1998 Dec; 3(6):381-5.
-
Huang L, Bosch I, Hofmann W, Sodroski J, Pardee AB. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. J Virol. 1998 Nov; 72(11):8952-60.
-
Ford HL, Kabingu EN, Bump EA, Mutter GL, Pardee AB. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A. 1998 Oct 13; 95(21):12608-13.
-
Zhang R, Averboukh L, Zhu W, Zhang H, Jo H, Dempsey PJ, Coffey RJ, Pardee AB, Liang P. Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation. Mol Cell Biol. 1998 Oct; 18(10):6131-41.
-
Martin KJ, Kwan CP, Nagasaki K, Zhang X, O'Hare MJ, Kaelin CM, Burgeson RE, Pardee AB, Sager R. Down-regulation of laminin-5 in breast carcinoma cells. Mol Med. 1998 Sep; 4(9):602-13.
-
Biswas DK, Mhashilkar AM, Ewaniuk DS, Pezza JA, Oh LM, Kannangara GS, Tius MA, Pardee AB. Inhibition of HIV-1 replication by combination of a novel inhibitor of TNF-alpha with AZT. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 15; 18(5):426-34.
-
Biswas DK, Averboukh L, Sheng S, Martin K, Ewaniuk DS, Jawde TF, Wang F, Pardee AB. Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol Med. 1998 Jul; 4(7):454-67.
-
Martin KJ, Kwan CP, O'Hare MJ, Pardee AB, Sager R. Identification and verification of differential display cDNAs using gene-specific primers and hybridization arrays. Biotechniques. 1998 Jun; 24(6):1018-26.
-
Zhao S, Molnar G, Zhang J, Zheng L, Averboukh L, Pardee AB. 3'-end cDNA pool suitable for differential display from a small number of cells. Biotechniques. 1998 May; 24(5):842-50, 852.
-
Sheng S, Truong B, Fredrickson D, Wu R, Pardee AB, Sager R. Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proc Natl Acad Sci U S A. 1998 Jan 20; 95(2):499-504.
-
Ford HL, Pardee AB. The S phase: beginning, middle, and end: a perspective. J Cell Biochem Suppl. 1998; 30-31:1-7.
-
Pardee AB. Complete genome expression monitoring: the human race. Nat Biotechnol. 1997 Dec; 15(13):1343-4.
-
Zhang M, Magit D, Pardee AB, Sager R. Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoter. Cancer Res. 1997 Oct 15; 57(20):4631-6.
-
Mhashilkar AM, Biswas DK, LaVecchio J, Pardee AB, Marasco WA. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. J Virol. 1997 Sep; 71(9):6486-94.
-
Huang L, Li CJ, Pardee AB. Human immunodeficiency virus type 1 TAT protein activates B lymphocytes. Biochem Biophys Res Commun. 1997 Aug 18; 237(2):461-4.
-
Li CJ, Ueda Y, Shi B, Borodyansky L, Huang L, Li YZ, Pardee AB. Tat protein induces self-perpetuating permissivity for productive HIV-1 infection. Proc Natl Acad Sci U S A. 1997 Jul 22; 94(15):8116-20.
-
Molnar GM, Crozat A, Kraeft SK, Dou QP, Chen LB, Pardee AB. Association of the mammalian helicase MAH with the pre-mRNA splicing complex. Proc Natl Acad Sci U S A. 1997 Jul 22; 94(15):7831-6.
-
Zhang JL, Sharma PL, Li CJ, Dezube BJ, Pardee AB, Crumpacker CS. Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase I. Antimicrob Agents Chemother. 1997 May; 41(5):977-81.
-
Zhang R, Zhang H, Zhu W, Pardee AB, Coffey RJ, Liang P. Mob-1, a Ras target gene, is overexpressed in colorectal cancer. Oncogene. 1997 Apr 3; 14(13):1607-10.
-
Dezube BJ, Ahlers CM, Lawrence JP, Teng EI, Silberman SL, Pardee AB, Finberg RW. Tenidap inhibits replication of the human immunodeficiency virus-1 in cultured cells. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1; 14(1):13-7.
-
Liang P, Pardee AB. Differential display. A general protocol. Methods Mol Biol. 1997; 85:3-11.
-
Averboukh L, Liang P, Douglas SA, Pardee AB. Hormone-inducible genes in prostate cells. Methods Mol Biol. 1997; 85:163-72.
-
Averboukh L, Liang P, Kantoff PW, Pardee AB. Regulation of S100P expression by androgen. Prostate. 1996 Dec; 29(6):350-5.
-
Alpan RS, Zhang M, Pardee AB. Cell cycle-dependent expression of TAP1, TAP2, and HLA-B27 messenger RNAs in a human breast cancer cell line. Cancer Res. 1996 Oct 1; 56(19):4358-61.
-
Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. Two differentially expressed genes in normal human prostate tissue and in carcinoma. Cancer Res. 1996 Aug 15; 56(16):3634-7.
-
Alpan RS, Sparvero S, Pardee AB. Identification of mRNAs differentially expressed in quiescence or in late G1 phase of the cell cycle in human breast cancer cells by using the differential display method. Mol Med. 1996 Jul; 2(4):469-78.
-
Alpan RS, Pardee AB. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ. 1996 Jul; 7(7):893-901.
-
Biswas DK, Tius MA, Zhuo J, Pardee AB. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1; 12(2):120-7.
-
Averboukh L, Douglas SA, Zhao S, Lowe K, Maher J, Pardee AB. Better gel resolution and longer cDNAs increase the precision of differential display. Biotechniques. 1996 May; 20(5):918-21.
-
Zhao S, Ooi SL, Yang FC, Pardee AB. Three methods for identification of true positive cloned cDNA fragment in differential display. Biotechniques. 1996 Mar; 20(3):400-4.
-
Dou QP, Pardee AB, Keyomarsi K. Cyclin E -- a better prognostic marker for breast cancer than cyclin D? Nat Med. 1996 Mar; 2(3):254.
-
Dou QP, Pardee AB. Transcriptional activation of thymidine kinase, a marker for cell cycle control. Prog Nucleic Acid Res Mol Biol. 1996; 53:197-217.
-
Biswas DK, Salas TR, Wang F, Ahlers CM, Dezube BJ, Pardee AB. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J Virol. 1995 Dec; 69(12):7437-44.
-
Liang P, Averboukh L, Zhu W, Haley T, Pardee AB. Molecular characterization of the murine thymidylate kinase gene. Cell Growth Differ. 1995 Oct; 6(10):1333-8.
-
Li CJ, Wang C, Pardee AB. Induction of apoptosis by beta-lapachone in human prostate cancer cells. Cancer Res. 1995 Sep 1; 55(17):3712-5.
-
Molnar G, O'Leary N, Pardee AB, Bradley DW. Quantification of DNA-protein interaction by UV crosslinking. Nucleic Acids Res. 1995 Aug 25; 23(16):3318-26.
-
Rohrwild M, Alpan RS, Liang P, Pardee AB. Inosine-containing primers for mRNA differential display. Trends Genet. 1995 Aug; 11(8):300.
-
Li CJ, Wang C, Friedman DJ, Pardee AB. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A. 1995 Jun 6; 92(12):5461-4.
-
Zhao S, Ooi SL, Pardee AB. New primer strategy improves precision of differential display. Biotechniques. 1995 May; 18(5):842-6, 848, 850.
-
Li CJ, Friedman DJ, Wang C, Metelev V, Pardee AB. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science. 1995 Apr 21; 268(5209):429-31.
-
Liang P, Pardee AB. Recent advances in differential display. Curr Opin Immunol. 1995 Apr; 7(2):274-80.
-
Liang P, Bauer D, Averboukh L, Warthoe P, Rohrwild M, Muller H, Strauss M, Pardee AB. Analysis of altered gene expression by differential display. Methods Enzymol. 1995; 254:304-21.
-
Dou QP, Molnar G, Pardee AB. Cyclin D1/cdk2 kinase is present in a G1 phase-specific protein complex Yi1 that binds to the mouse thymidine kinase gene promoter. Biochem Biophys Res Commun. 1994 Dec 30; 205(3):1859-68.
-
Liang P, Zhu W, Zhang X, Guo Z, O'Connell RP, Averboukh L, Wang F, Pardee AB. Differential display using one-base anchored oligo-dT primers. Nucleic Acids Res. 1994 Dec 25; 22(25):5763-4.
-
Liang P, Averboukh L, Zhu W, Pardee AB. Ras activation of genes: Mob-1 as a model. Proc Natl Acad Sci U S A. 1994 Dec 20; 91(26):12515-9.
-
Biswas DK, Ahlers CM, Dezube BJ, Pardee AB. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol Med. 1994 Nov; 1(1):31-43.
-
Bradley DW, Fridovich-Keil JL, Gudas JM, Pardee AB. Serum-responsive expression from the murine thymidine kinase promoter is specifically disrupted in a transformed cell line. Cell Growth Differ. 1994 Oct; 5(10):1137-43.
-
Molnar G, Crozat A, Pardee AB. The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol. 1994 Aug; 14(8):5242-8.
-
Pardee AB. Proteins in five dimensions. Protein Sci. 1994 Jul; 3(7):1136-9.
-
Li CJ, Dezube BJ, Biswas DK, Ahlers CM, Pardee AB. Inhibitors of HIV-1 transcription. Trends Microbiol. 1994 May; 2(5):164-9.
-
Pardee AB. Multiple molecular levels of cell cycle regulation. J Cell Biochem. 1994 Apr; 54(4):375-8.
-
Li CJ, Wang C, Pardee AB. Camptothecin inhibits Tat-mediated transactivation of type 1 human immunodeficiency virus. J Biol Chem. 1994 Mar 11; 269(10):7051-4.
-
Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 1994 Jan 15; 54(2):380-5.
-
Dou QP, Zhao S, Levin AH, Wang J, Helin K, Pardee AB. G1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J Biol Chem. 1994 Jan 14; 269(2):1306-13.
-
Pardee AB. Growth dysregulation in cancer cells. Adv Cancer Res. 1994; 65:213-28.
-
Biswas DK, Ahlers CM, Dezube BJ, Pardee AB. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat. Proc Natl Acad Sci U S A. 1993 Dec 1; 90(23):11044-8.
-
Li CJ, Averboukh L, Pardee AB. beta-Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin. J Biol Chem. 1993 Oct 25; 268(30):22463-8.
-
Fridovich-Keil JL, Markell PJ, Gudas JM, Pardee AB. DNA sequences required for serum-responsive regulation of expression from the mouse thymidine kinase promoter. Cell Growth Differ. 1993 Aug; 4(8):679-87.
-
Keyomarsi K, Samet J, Molnar G, Pardee AB. The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme. J Biol Chem. 1993 Jul 15; 268(20):15142-9.
-
Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNAs by means of differential display: refinements and optimization. Nucleic Acids Res. 1993 Jul 11; 21(14):3269-75.
-
Dezube BJ, Pardee AB, Chapman B, Beckett LA, Korvick JA, Novick WJ, Chiurco J, Kasdan P, Ahlers CM, Ecto LT, et al. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. NIAID AIDS Clinical Trials Group. J Acquir Immune Defic Syndr. 1993 Jul; 6(7):787-94.
-
Biswas DK, Dezube BJ, Ahlers CM, Pardee AB. Pentoxifylline inhibits HIV-1 LTR-driven gene expression by blocking NF-kappa B action. J Acquir Immune Defic Syndr. 1993 Jul; 6(7):778-86.
-
Gudas JM, Fridovich-Keil JL, Pardee AB. Posttranscriptional control of thymidine kinase messenger RNA accumulation in cells released from G0-G1 phase blocks. Cell Growth Differ. 1993 May; 4(5):421-30.
-
Dou QP, Levin AH, Zhao S, Pardee AB. Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res. 1993 Apr 1; 53(7):1493-7.
-
Li CJ, Zhang LJ, Dezube BJ, Crumpacker CS, Pardee AB. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci U S A. 1993 Mar 1; 90(5):1839-42.
-
Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A. 1993 Feb 1; 90(3):1112-6.
-
Dezube BJ, Sherman ML, Fridovich-Keil JL, Allen-Ryan J, Pardee AB. Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study. Cancer Immunol Immunother. 1993; 36(1):57-60.
-
Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 1992 Dec 15; 52(24):6966-8.
-
Gudas JM, Fridovich-Keil JL, Datta MW, Bryan J, Pardee AB. Characterization of the murine thymidine kinase-encoding gene and analysis of transcription start point heterogeneity. Gene. 1992 Sep 10; 118(2):205-16.
-
Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992 Aug 14; 257(5072):967-71.
-
Dou QP, Markell PJ, Pardee AB. Thymidine kinase transcription is regulated at G1/S phase by a complex that contains retinoblastoma-like protein and a cdc2 kinase. Proc Natl Acad Sci U S A. 1992 Apr 15; 89(8):3256-60.
-
Pardee AB, Keyomarsi K. Modification of cell proliferation with inhibitors. Curr Opin Cell Biol. 1992 Apr; 4(2):186-91.
-
Dezube BJ, Pardee AB, Beckett LA, Ahlers CM, Ecto L, Allen-Ryan J, Anisowicz A, Sager R, Crumpacker CS. Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO. J Acquir Immune Defic Syndr. 1992; 5(11):1099-104.
-
Fridovich-Keil JL, Gudas JM, Bryan IB, Pardee AB. Improved expression vectors for eukaryotic promoter/enhancer studies. Biotechniques. 1991 Nov; 11(5):572-9.
-
Teicher BA, Holden SA, Herman TS, Epelbaum R, Pardee AB, Dezube B. Efficacy of pentoxifylline as a modulator of alkylating agent activity in vitro and in vivo. Anticancer Res. 1991 Jul-Aug; 11(4):1555-60.
-
Keyomarsi K, Sandoval L, Band V, Pardee AB. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res. 1991 Jul 1; 51(13):3602-9.
-
Fazely F, Dezube BJ, Allen-Ryan J, Pardee AB, Ruprecht RM. Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells. Blood. 1991 Apr 15; 77(8):1653-6.
-
Dou QP, Fridovich-Keil JL, Pardee AB. Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase. Proc Natl Acad Sci U S A. 1991 Feb 15; 88(4):1157-61.
-
Fridovich-Keil JL, Gudas JM, Dou QP, Bouvard I, Pardee AB. Growth-responsive expression from the murine thymidine kinase promoter: genetic analysis of DNA sequences. Cell Growth Differ. 1991 Feb; 2(2):67-76.
-
Teicher BA, Herman TS, Tanaka J, Dezube B, Pardee A, Frei E. Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma. Cancer Chemother Pharmacol. 1991; 28(1):45-50.
-
Nikaido T, Bradley DW, Pardee AB. Molecular cloning of transcripts that accumulate during the late G1 phase in cultured mouse cells. Exp Cell Res. 1991 Jan; 192(1):102-9.
-
Bradley DW, Dou QP, Fridovich-Keil JL, Pardee AB. Transformed and nontransformed cells differ in stability and cell cycle regulation of a binding activity to the murine thymidine kinase promoter. Proc Natl Acad Sci U S A. 1990 Dec; 87(23):9310-4.
-
Fridovich-Keil JL, Hansen LJ, Keyomarsi K, Pardee AB. Progression through the cell cycle: an overview. Am Rev Respir Dis. 1990 Dec; 142(6 Pt 2):S3-6.
-
Dezube BJ, Eder JP, Pardee AB. Phase I trial of escalating pentoxifylline dose with constant dose thiotepa. Cancer Res. 1990 Nov 1; 50(21):6806-10.
-
Geller AI, Keyomarsi K, Bryan J, Pardee AB. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci U S A. 1990 Nov; 87(22):8950-4.
-
Gudas JM, Knight GB, Pardee AB. Ordered splicing of thymidine kinase pre-mRNA during the S phase of the cell cycle. Mol Cell Biol. 1990 Oct; 10(10):5591-5.
-
Dezube BJ, Fridovich-Keil JL, Bouvard I, Lange RF, Pardee AB. Pentoxifylline and wellbeing in patients with cancer. Lancet. 1990 Mar 17; 335(8690):662.
-
Boothman DA, Hughes EN, Pardee AB. The role of X-ray-induced DNA repair processes in mutagenesis and carcinogenesis. Prog Clin Biol Res. 1990; 340E:319-27.
-
Boothman DA, Geller AI, Pardee AB. Expression of the E. coli Lac Z gene from a defective HSV-1 vector in various human normal, cancer-prone and tumor cells. FEBS Lett. 1989 Nov 20; 258(1):159-62.
-
Pardee AB. G1 events and regulation of cell proliferation. Science. 1989 Nov 3; 246(4930):603-8.
-
Boothman DA, Pardee AB. Inhibition of radiation-induced neoplastic transformation by beta-lapachone. Proc Natl Acad Sci U S A. 1989 Jul; 86(13):4963-7.
-
Knight GB, Gudas JM, Pardee AB. Coordinate control of S phase onset and thymidine kinase expression. Jpn J Cancer Res. 1989 Jun; 80(6):493-8.
-
Nikaido T, Shimada K, Nishida Y, Lee RS, Pardee AB, Nishizuka Y. Loss in transformed cells of cell cycle regulation of expression of a nuclear protein recognized by SLE patient antisera. Exp Cell Res. 1989 May; 182(1):284-9.
-
Boothman DA, Trask DK, Pardee AB. Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I. Cancer Res. 1989 Feb 1; 49(3):605-12.
-
Boothman DA, Schlegel R, Pardee AB. Anticarcinogenic potential of DNA-repair modulators. Mutat Res. 1988 Dec; 202(2):393-411.
-
Fingert HJ, Pu AT, Chen ZY, Googe PB, Alley MC, Pardee AB. In vivo and in vitro enhanced antitumor effects by pentoxifylline in human cancer cells treated with thiotepa. Cancer Res. 1988 Aug 1; 48(15):4375-81.
-
Gudas JM, Knight GB, Pardee AB. Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis. Proc Natl Acad Sci U S A. 1988 Jul; 85(13):4705-9.
-
Verma R, Iida H, Pardee AB. Identification of a novel stress-inducible glycoprotein in Saccharomyces cerevisiae. I. Preliminary characterization. J Biol Chem. 1988 Jun 25; 263(18):8569-75.
-
Verma R, Iida H, Pardee AB. Modulation of expression of the stress-inducible p118 of Saccharomyces cerevisiae by cAMP. II. A study of p118 expression in mutants of the cAMP cascade. J Biol Chem. 1988 Jun 25; 263(18):8576-82.
-
Woodford TA, Schlegel R, Pardee AB. Selective isolation of newly synthesized mammalian mRNA after in vivo labeling with 4-thiouridine or 6-thioguanosine. Anal Biochem. 1988 May 15; 171(1):166-72.
-
Knight GB, Gudas JM, Pardee AB. Cell-cycle-specific interaction of nuclear DNA-binding proteins with a CCAAT sequence from the human thymidine kinase gene. Proc Natl Acad Sci U S A. 1987 Dec; 84(23):8350-4.
-
Schlegel R, Pardee AB. Periodic mitotic events induced in the absence of DNA replication. Proc Natl Acad Sci U S A. 1987 Dec; 84(24):9025-9.
-
Yang HC, Pardee AB. Cell cycle and growth factor-dependent phosphoprotein of 78kD differently regulated in normal and transformed mouse fibroblasts. J Cell Physiol. 1987 Nov; 133(2):377-82.
-
Boothman DA, Greer S, Pardee AB. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor. Cancer Res. 1987 Oct 15; 47(20):5361-6.
-
Ober SS, Pardee AB. Both protein kinase C and calcium mediate activation of the Na+/H+ antiporter in Chinese hamster embryo fibroblasts. J Cell Physiol. 1987 Aug; 132(2):311-7.
-
Coppock DL, Pardee AB. Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol. 1987 Aug; 7(8):2925-32.
-
Forsgren A, Bredberg A, Pardee AB, Schlossman SF, Tedder TF. Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth. Antimicrob Agents Chemother. 1987 May; 31(5):774-9.
-
Ober SS, Pardee AB. Intracellular pH is increased after transformation of Chinese hamster embryo fibroblasts. Proc Natl Acad Sci U S A. 1987 May; 84(9):2766-70.
-
Schlegel R, Croy RG, Pardee AB. Exposure to caffeine and suppression of DNA replication combine to stabilize the proteins and RNA required for premature mitotic events. J Cell Physiol. 1987 Apr; 131(1):85-91.
-
Pardee AB. Molecules involved in proliferation of normal and cancer cells: presidential address. Cancer Res. 1987 Mar 15; 47(6):1488-91.
-
Pardee AB. The Yang and Yin of cell proliferation: an overview. J Cell Physiol Suppl. 1987; Suppl 5:107-10.
-
Godeau F, Persson H, Gray HE, Pardee AB. C-myc expression is dissociated from DNA synthesis and cell division in Xenopus oocyte and early embryonic development. EMBO J. 1986 Dec 20; 5(13):3571-7.
-
Schlegel R, Pardee AB. Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells. Science. 1986 Jun 6; 232(4755):1264-6.
-
Yang HC, Pardee AB. Insulin-like growth factor I regulation of transcription and replicating enzyme induction necessary for DNA synthesis. J Cell Physiol. 1986 Jun; 127(3):410-6.
-
Pardee AB. Biochemical and molecular events regulating cell proliferation. J Pathol. 1986 May; 149(1):1-2.
-
Fingert HJ, Chang JD, Pardee AB. Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents. Cancer Res. 1986 May; 46(5):2463-7.
-
Woodford TA, Pardee AB. Histone H1 kinase in exponential and synchronous populations of Chinese hamster fibroblasts. J Biol Chem. 1986 Apr 5; 261(10):4669-76.
-
Reddy GP, Klinge EM, Pardee AB. Ribonucleotides are channeled into a mixed DNA-RNA polymer by permeabilized hamster cells. Biochem Biophys Res Commun. 1986 Feb 26; 135(1):340-6.
-
Pardee AB, Coppock DL, Yang HC. Regulation of cell proliferation at the onset of DNA synthesis. J Cell Sci Suppl. 1986; 4:171-80.
-
Coppock DL, Pardee AB. Regulation of thymidine kinase activity in the cell cycle by a labile protein. J Cell Physiol. 1985 Aug; 124(2):269-74.
-
Gronostajski RM, Pardee AB, Goldberg AL. The ATP dependence of the degradation of short- and long-lived proteins in growing fibroblasts. J Biol Chem. 1985 Mar 25; 260(6):3344-9.
-
Fingert HJ, Treiman A, Pardee AB. Transplantation of human or rodent tumors into cyclosporine-treated mice: a feasible model for studies of tumor biology and chemotherapy. Proc Natl Acad Sci U S A. 1984 Dec; 81(24):7927-31.
-
Fingerman E, Campisi J, Pardee AB. Defective Ca2+ metabolism in Duchenne muscular dystrophy: effects on cellular and viral growth. Proc Natl Acad Sci U S A. 1984 Dec; 81(23):7617-21.
-
Gronostajski RM, Goldberg AL, Pardee AB. The role of increased proteolysis in the atrophy and arrest of proliferation in serum-deprived fibroblasts. J Cell Physiol. 1984 Oct; 121(1):189-98.
-
Campisi J, Pardee AB. Post-transcriptional control of the onset of DNA synthesis by an insulin-like growth factor. Mol Cell Biol. 1984 Sep; 4(9):1807-14.
-
Fingert HJ, Kindy RL, Pardee AB. Enhanced lethality by methylxanthines in human bladder cancer cells treated with thiotepa. J Urol. 1984 Sep; 132(3):609-13.
-
Boorstein RJ, Pardee AB. 3-Aminobenzamide is lethal to MMS-damaged human fibroblasts primarily during S phase. J Cell Physiol. 1984 Sep; 120(3):345-53.
-
Boorstein RJ, Pardee AB. Factors modifying 3-aminobenzamide cytotoxicity in normal and repair-deficient human fibroblasts. J Cell Physiol. 1984 Sep; 120(3):335-44.
-
Campisi J, Morreo G, Pardee AB. Kinetics of G1 transit following brief starvation for serum factors. Exp Cell Res. 1984 Jun; 152(2):459-66.
-
Gronostajski RM, Pardee AB. Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells. J Cell Physiol. 1984 Apr; 119(1):127-32.
-
Gronostajski RM, Goldberg AL, Pardee AB. Energy requirement for degradation of tumor-associated protein p53. Mol Cell Biol. 1984 Mar; 4(3):442-8.
-
Boorstein RJ, Pardee AB. Beta-lapachone greatly enhances MMS lethality to human fibroblasts. Biochem Biophys Res Commun. 1984 Feb 14; 118(3):828-34.
-
Das SK, Lau CC, Pardee AB. Comparative analysis of caffeine and 3-aminobenzamide as DNA repair inhibitors in Syrian baby hamster kidney cells. Mutat Res. 1984 Feb; 131(2):71-9.
-
Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE. Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell. 1984 Feb; 36(2):241-7.
-
Pardee AB, Campisi J, Gray HE, Dean M, Sonenshein G. Cellular oncogenes, growth factors, and cellular growth control. Symp Fundam Cancer Res. 1984; 37:21-9.
-
Boorstein RJ, Pardee AB. Coordinate inhibition of DNA synthesis and thymidylate synthase activity following DNA damage and repair. Biochem Biophys Res Commun. 1983 Nov 30; 117(1):30-6.
-
Croy RG, Pardee AB. Enhanced synthesis and stabilization of Mr 68,000 protein in transformed BALB/c-3T3 cells: candidate for restriction point control of cell growth. Proc Natl Acad Sci U S A. 1983 Aug; 80(15):4699-703.
-
veer Reddy GP, Pardee AB. Inhibitor evidence for allosteric interaction in the replitase multienzyme complex. Nature. 1983 Jul 7-13; 304(5921):86-8.
-
Boorstein R, Campisi J, Pardee AB. The study of DNA-repair defects using [125I]iododeoxycytidine incorporation as an assay for the growth of herpes simplex virus. Mutat Res. 1983 Apr; 112(2):85-95.
-
Noguchi H, Prem veer Reddy G, Pardee AB. Rapid incorporation of label from ribonucleoside disphosphates into DNA by a cell-free high molecular weight fraction from animal cell nuclei. Cell. 1983 Feb; 32(2):443-51.
-
Pardee AB, Boorstein RJ, Lau CC. Interference with DNA repair mechanisms of mammalian cells: cell cycle dependence. Princess Takamatsu Symp. 1983; 13:287-94.
-
Campisi J, Hafner J, Boorstein R, Pardee AB. Hereditary orotic aciduria, Lesch-Nyhan syndrome, and xeroderma pigmentosum probed by herpes simplex virus: 125I-iododeoxycytidine incorporation as an assay for viral growth. J Cell Physiol. 1983 Jan; 114(1):21-8.
-
Pardee AB, Campisi J, Croy RG. Differences in growth regulation of normal and tumor cells. Ann N Y Acad Sci. 1982 Dec 10; 397:121-9.
-
veer Reddy GP, Pardee AB. Coupled ribonucleoside diphosphate reduction, channeling, and incorporation into DNA of mammalian cells. J Biol Chem. 1982 Nov 10; 257(21):12526-31.
-
Das SK, Lau CC, Pardee AB. Abolition by cycloheximide of caffeine-enhanced lethality of alkylating agents in hamster cells. Cancer Res. 1982 Nov; 42(11):4499-504.
-
Campisi J, Pardee AB. An artifact in measurement of S phase initiation and its implication for the kinetics of S phase-specific enzyme activities. Exp Cell Res. 1982 Aug; 140(2):389-93.
-
Lau CC, Pardee AB. Mechanism by which caffeine potentiates lethality of nitrogen mustard. Proc Natl Acad Sci U S A. 1982 May; 79(9):2942-6.
-
Campisi J, Medrano EE, Morreo G, Pardee AB. Restriction point control of cell growth by a labile protein: evidence for increased stability in transformed cells. Proc Natl Acad Sci U S A. 1982 Jan; 79(2):436-40.
-
Campisi J, Pardee AB. Cellular mutations and drug resistance probed by herpes simplex virus. J Cell Physiol. 1981 Dec; 109(3):469-80.
-
Kim K, Blechman WJ, Riddle VG, Pardee AB. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations. Cancer Res. 1981 Nov; 41(11 Pt 1):4529-34.
-
Pardee AB, Cherington PV, Medrano EE. On deciding which factors regulate cell growth. Prog Clin Biol Res. 1981; 66 Pt A:495-502.
-
Cherington PV, Pardee AB. Synergistic effects of epidermal growth factor and thrombin on the growth stimulation of diploid Chinese hamster fibroblasts. J Cell Physiol. 1980 Oct; 105(1):25-32.
-
Medrano EE, Pardee AB. Prevalent deficiency in tumor cells of cycloheximide-induced cycle arrest. Proc Natl Acad Sci U S A. 1980 Jul; 77(7):4123-6.
-
Prem veer Reddy G, Pardee AB. Multienzyme complex for metabolic channeling in mammalian DNA replication. Proc Natl Acad Sci U S A. 1980 Jun; 77(6):3312-16.
-
Riddle VG, Pardee AB. Quiescent cells but not cycling cells exhibit enhanced actin synthesis before they synthesize DNA. J Cell Physiol. 1980 Apr; 103(1):11-5.
-
Moscovitis G, Pardee AB. Citric acid arrest and stabilization of nucleoside incorporation into cultured cells. Anal Biochem. 1980 Jan 1; 101(1):221-4.
-
Shilo B, Riddle VG, Pardee AB. Protein turnover and cell-cycle initiation in yeast. Exp Cell Res. 1979 Oct 15; 123(2):221-7.
-
Rossow PW, Riddle VG, Pardee AB. Synthesis of labile, serum-dependent protein in early G1 controls animal cell growth. Proc Natl Acad Sci U S A. 1979 Sep; 76(9):4446-50.
-
Castellot JJ, Miller MR, Lehtomaki DM, Pardee AB. Comparison of DNA replication and repair enzymology using permeabilized baby hamster kidney cells. J Biol Chem. 1979 Aug 10; 254(15):6904-8.
-
Cherington PV, Smith BL, Pardee AB. Loss of epidermal growth factor requirement and malignant transformation. Proc Natl Acad Sci U S A. 1979 Aug; 76(8):3937-41.
-
Tucker RW, Pardee AB, Fujiwara K. Centriole ciliation is related to quiescence and DNA synthesis in 3T3 cells. Cell. 1979 Jul; 17(3):527-35.
-
Dubrow R, Riddle VG, Pardee AB. Different responses to drugs and serum of cells transformed by various means. Cancer Res. 1979 Jul; 39(7 Pt 1):2718-26.
-
Yen A, Pardee AB. Role of nuclear size in cell growth initiation. Science. 1979 Jun 22; 204(4399):1315-7.
-
Miller MR, Castellot JJ, Pardee AB. A general method for permeabilizing monolayer and suspension cultured animal cells. Exp Cell Res. 1979 May; 120(2):421-5.
-
Riddle VG, Dubrow R, Pardee AB. Changes in the synthesis of actin and other cell proteins after stimulation of serum-arrested cells. Proc Natl Acad Sci U S A. 1979 Mar; 76(3):1298-302.
-
Satta G, Gudas LJ, Pardee AB. Degradation of Escherichia coli DNA: evidence for limitation in vivo by protein X, the recA gene product. Mol Gen Genet. 1979 Jan 5; 168(1):69-80.
-
Riddle VG, Pardee AB, Rossow PW. Growth control of normal and transformed cells. J Supramol Struct. 1979; 11(4):529-38.
-
Shilo B, Simchen G, Pardee AB. Regulation of cell-cycle initiation in yeast by nutrients and protein synthesis. J Cell Physiol. 1978 Nov; 97(2):177-87.
-
Yen A, Pardee AB. Exponential 3T3 cells escape in mid-G1 from their high serum requirement. Exp Cell Res. 1978 Oct 1; 116(1):103-13.
-
Yen A, Pardee AB. Arrested states produced by isoleucine deprivation and their relationship to the low serum produced arrested state in Swiss 3T3 cells. Exp Cell Res. 1978 Jul; 114(2):389-95.
-
Yen A, Warrington RC, Pardee AB. Serum-stimulated 3T3 cells undertake a histidinol-sensitive process which G1 cells do not. Exp Cell Res. 1978 Jul; 114(2):458-62.
-
Dubrow R, Pardee AB, Pollack R. 2-amino-isobutyric acid and 3-O-methyl-D-glucose transport in 3T3, SV 40-transformed 3T3 and revertant cell lines. J Cell Physiol. 1978 May; 95(2):203-11.
-
Miller MR, Castellot JJ, Pardee AB. A permeable animal cell preparation for studying macromolecular synthesis. DNA synthesis and the role of deoxyribonucleotides in S phase initiation. Biochemistry. 1978 Mar 21; 17(6):1073-80.
-
Satta G, Pardee AB. Inhibition of Escherichia coli division by protein X. J Bacteriol. 1978 Mar; 133(3):1492-500.
-
Castellot JJ, Miller MR, Pardee AB. Animal cells reversibly permeable to small molecules. Proc Natl Acad Sci U S A. 1978 Jan; 75(1):351-5.
-
Hamlin JL, Pardee AB. Control of DNA synthesis in tissue culture cells. In Vitro. 1978 Jan; 14(1):119-27.
-
Pardee AB, Dubrow R, Hamlin JL, Kletzien RF. Animal cell cycle. Annu Rev Biochem. 1978; 47:715-50.
-
Kletzien RF, Miller MR, Pardee AB. Unique cytoplasmic phosphoproteins are associated with cell growth arrest. Nature. 1977 Nov 3; 270(5632):57-9.
-
Pardee AB, Dubrow R. Control of cell proliferation. Cancer. 1977 Jun; 39(6 Suppl):2747-54.
-
Hamlin JL, Pardee AB. S phase synchrony in monolayer CHO cultures. Exp Cell Res. 1976 Jul; 100(2):265-75.
-
Gudas LJ, Pardee AB. DNA synthesis inhibition and the induction of protein X in Escherichia coli. J Mol Biol. 1976 Mar 15; 101(4):459-77.
-
Pardee AB, James LJ. Selective killing of transformed baby hamster kidney (BHK) cells. Proc Natl Acad Sci U S A. 1975 Dec; 72(12):4994-8.
-
Pardee AB. The cell surface and fibroblast proliferation some current research trends. Biochim Biophys Acta. 1975 Jul 11; 417(2):153-72.
-
James R, Haga JY, Pardee AB. Inhibition of an early event in the cell division cycle of Escherichia coli by FL1060, an amidinopenicillanic acid. J Bacteriol. 1975 Jun; 122(3):1283-92.
-
Gudas LJ, Pardee AB. Model for regulation of Escherichia coli DNA repair functions. Proc Natl Acad Sci U S A. 1975 Jun; 72(6):2330-4.
-
Spratt BG, Pardee AB. Penicillin-binding proteins and cell shape in E. coli. Nature. 1975 Apr 10; 254(5500):516-7.
-
Fournier RE, Pardee AB. Cell cycle studies of mononucleate and cytochalasin-B--nduced binucleate fibroblasts. Proc Natl Acad Sci U S A. 1975 Mar; 72(3):869-73.
-
Fournier RE, Pardee AB. Evidence for inducible, L-malate binding proteins in the membrane of Bacillus subtilis. Identification of presumptive components of the C4-dicarboxylate transport systems. J Biol Chem. 1974 Sep 25; 249(18):5948-54.
-
Pardee AB. A restriction point for control of normal animal cell proliferation. Proc Natl Acad Sci U S A. 1974 Apr; 71(4):1286-90.
-
Pardee AB. The sixth Sir Hans Krebs lecture: the biochemical requirements for bacterial division. In pursuit of protein X. Eur J Biochem. 1974 Apr 1; 43(2):209-13.
-
Gudas LJ, Pardee AB. Deoxyribonucleic acid synthesis during the division cycle of Escherichia coli: a comparison of strains B-r, K-12, 15, and 15T- under conditions of slow growth. J Bacteriol. 1974 Mar; 117(3):1216-23.
-
Pardee A. Isolation of membrane proteins. Neurosci Res Program Bull. 1973 Jun; 11(3):195-8.
-
Wu PC, Pardee AB. Cell division of Escherichia coli: control by membrane organization. J Bacteriol. 1973 May; 114(2):603-11.
-
Pardee AB, Palmer LM. Regulation of transport systems: a means of controlling metabolic rates. Symp Soc Exp Biol. 1973; 27:133-44.
-
Rozengurt E, Pardee AB. Opposite effects of dibutyryl adenosine 3':5' cyclic monophosphate and serum on growth of Chinese hamster cells. J Cell Physiol. 1972 Oct; 80(2):273-9.
-
Sander G, Pardee AB. Transport changes in synchronously growing CHO and L cells. J Cell Physiol. 1972 Oct; 80(2):267-71.
-
Fournier RE, McKillen MN, Pardee AB, Willecke K. Transport of dicarboxylic acids in Bacillus subtilis. Inducible uptake of L-malate. J Biol Chem. 1972 Sep 10; 247(17):5587-95.
-
Zusman DR, Inouye M, Pardee AB. Cell division in Escherichia coli: evidence for regulation of septation by effector molecules. J Mol Biol. 1972 Aug 14; 69(1):119-36.
-
Pardee AB. Captive audience. Science. 1972 Mar 17; 175(4027):1194.
-
Pardee AB, Benz EJ, St Peter DA, Krieger JN, Meuth M, Trieshmann HW. Hyperproduction and purification of nicotinamide deamidase, a microconstitutive enzyme of Escherichia coli. J Biol Chem. 1971 Nov 25; 246(22):6792-6.
-
Fox TO, Pardee AB. Proteins made in the mammalian cell cycle. J Biol Chem. 1971 Oct 25; 246(20):6159-65.
-
Willecke K, Pardee AB. Fatty acid-requiring mutant of bacillus subtilis defective in branched chain alpha-keto acid dehydrogenase. J Biol Chem. 1971 Sep 10; 246(17):5264-72.
-
Ota N, Galsworthy PR, Pardee AB. Genetics of sulfate transport by Salmonella typhimurium. J Bacteriol. 1971 Mar; 105(3):1053-62.
-
Willecke K, Pardee AB. Inducible transport of citrate in a Gram-positive bacterium, Bacillus subtilis. J Biol Chem. 1971 Feb 25; 246(4):1032-40.
-
Pardee AB. Control of metabolic reactions by feedback inhibition. Harvey Lect. 1971; 65:59-71.
-
Inouye M, Pardee AB. Changes of membrane proteins and their relation to deoxyribonucleic acid synthesis and cell division of Escherichia coli. J Biol Chem. 1970 Nov 10; 245(21):5813-9.
-
Langridge R, Shinagawa H, Pardee AB. Sulfate-binding protein from Salmonella typhimurium: physical properties. Science. 1970 Jul 3; 169(3940):59-61.
-
Eisenberg RJ, Pardee AB. Gene photoinactivation in Escherichia coli which contain 5-bromodeoxyuridine-substituted DNA. Biochim Biophys Acta. 1970 Mar 19; 204(1):112-9.
-
Inouye M, Pardee AB. Requirement of polyamines for bacterial division. J Bacteriol. 1970 Mar; 101(3):770-6.
-
Smith HS, Pardee AB. Accumulation of a protein required for division during the cell cycle of Escherichia coli. J Bacteriol. 1970 Mar; 101(3):901-9.
-
Fox TO, Pardee AB. Animal cells: noncorrelation of length of G1 phase with size after mitosis. Science. 1970 Jan 2; 167(3914):80-2.
-
Eisenberg RJ, Pardee AB. DNA replication during episome transfer as studied by bromodeoxyuridine photosensitization. J Mol Biol. 1969 Dec 14; 46(2):355-8.
-
Cunningham DD, Pardee AB. Transport changes rapidly initiated by serum addition to "contact inhibited" 3T3 cells. Proc Natl Acad Sci U S A. 1969 Nov; 64(3):1049-56.
-
Foster DO, Pardee AB. Transport of amino acids by confluent and nonconfluent 3T3 and polyoma virus-transformed 3T3 cells growing on glass cover slips. J Biol Chem. 1969 May 25; 244(10):2675-81.
-
Pardee AB. Membrane transport proteins. Proteins that appear to be parts of membrane transport systems are being isolated and characterized. Science. 1968 Nov 8; 162(3854):632-7.
-
Pardee AB, Watanabe K. Location of sulfate-binding protein in Salmonella typhimurium. J Bacteriol. 1968 Oct; 96(4):1049-54.
-
Pardee AB. Control of cell division: models from microorganisms. Cancer Res. 1968 Sep; 28(9):1802-9.
-
Pardee AB. Biochemical studies on active transport. J Gen Physiol. 1968 Jul 1; 52(1):279-95.
-
Pardee AB. Biochemical studies on active transport. J Gen Physiol. 1968 Jul; 52(1):279Suppl-95s.
-
Ohta N, Pardee AB, McAuslan BR, Burger MM. Sialic acid contents and controls of normal and malignant cells. Biochim Biophys Acta. 1968 Apr 16; 158(1):98-102.
-
Walker JR, Pardee AB. Evidence for a relationship between deoxyribonucleic acid metabolism and septum formation in Escherichia coli. J Bacteriol. 1968 Jan; 95(1):123-31.
-
Fisher DB, Pardee AB. The Luria-Latarjet effect studied by T4-lysozyme production. Virology. 1968 Jan; 34(1):91-6.
-
Pardee AB. Regulation of active transport. Natl Cancer Inst Monogr. 1967 Nov; 27:249-57.
-
Budman DR, Pardee AB. Thymidine and thymine incorporation into deoxyribonucleic acid: inhibition and repression by uridine of thymidine phosphorylase of Escherichia coli. J Bacteriol. 1967 Nov; 94(5):1546-50.
-
Long CW, Pardee AB. Cytidine triphosphate synthetase of Escherichia coli B. I. Purification and kinetics. J Biol Chem. 1967 Oct 25; 242(20):4715-21.
-
Pardee AB. Crystallization of a sulfate-binding protein (permease) from Salmonella typhimurium. Science. 1967 Jun 23; 156(3782):1627-8.
-
Pardee AB, Prestidge LS. Ultraviolet-sensitive targets in the enzyme-synthesizing apparatus of Escherichia coli. J Bacteriol. 1967 Apr; 93(4):1210-9.
-
Kadish LJ, Fisher DB, Pardee AB. Photodynamic inactivation of free and vegatative bacteriophage T4. Biochim Biophys Acta. 1967 Mar 29; 138(1):57-65.
-
Walker JR, Pardee AB. Conditional mutations involving septum formation in Escherichia coli. J Bacteriol. 1967 Jan; 93(1):107-14.
-
Pardee AB. Purification and properties of a sulfate-binding protein from Salmonella typhimurium. J Biol Chem. 1966 Dec 25; 241(24):5886-92.
-
Barbour SD, Pardee AB. The establishment of beta-galactosidase repression in the mating system of Escherichia coli K12. J Mol Biol. 1966 Oct; 20(3):505-15.
-
Pardee AB, Prestidge LS, Whipple MB, Dreyfuss J. A binding site for sulfate and its relation to sulfate transport into Salmonella typhimurium. J Biol Chem. 1966 Sep 10; 241(17):3962-9.
-
Pardee AB. [Periodicity in bacterial cell cycles]. Tanpakushitsu Kakusan Koso. 1966 Sep; 11(10):829-36.
-
Glick JL, Goldberg AR, Pardee AB. The role of sialic acid in the release of proteins from L1210 leukemia cells. Cancer Res. 1966 Aug; 26(8):1774-7.
-
Goldberg AR, Machledt JH, Pardee AB. On the action of fluorouracil on leukemia cells. Cancer Res. 1966 Aug; 26(8):1611-5.
-
Morris DR, Pardee AB. Multiple pathways of putrescine biosynthesis in Escherichia coli. J Biol Chem. 1966 Jul 10; 241(13):3129-35.
-
Dreyfuss J, Pardee AB. Regulation of sulfate transport in Salmonella typhimurium. J Bacteriol. 1966 Jun; 91(6):2275-80.
-
Pardee AB, Prestidge LS. Cell-free activity of a sulfate binding site involved in active transport. Proc Natl Acad Sci U S A. 1966 Jan; 55(1):189-91.
-
Herman RK, Pardee AB. On the stability of m-RNA in a polar mutant. Biochim Biophys Acta. 1965 Nov 8; 108(3):513-5.
-
Morris DR, Pardee AB. A biosynthetic ornithine decarboxylase in Escherichia coli. Biochem Biophys Res Commun. 1965 Sep 22; 20(6):697-702.
-
Masters M, Pardee AB. Sequence of enzyme synthesis and gene replication during the cell cycle of Bacillus subtilis. Proc Natl Acad Sci U S A. 1965 Jul; 54(1):64-70.
-
Dreyfuss J, Pardee AB. Evidence for a sulfate-binding site external to the cell membrane of Salmonella typhimurium. Biochim Biophys Acta. 1965 Jun 15; 104(1):308-10.
-
PRESTIDGE LS, PARDEE AB. A SECOND PERMEASE FOR METHYL-THIO-BETA-D-GALACTOSIDE IN ESCHERICHIA COLI. Biochim Biophys Acta. 1965 May 4; 100:591-3.
-
GERHART JC, PARDEE AB. ASPARTATE TRANSCARBAMYLASE, AN ENZYME DESIGNED FOR FEEDBACK INHIBITION. Fed Proc. 1964 May-Jun; 23:727-35.
-
TAYLOR AL, BECKWITH JR, PARDEE AB, AUSTRIAN R, JACOB F. THE CHROMOSOMAL LOCATION OF THE STRUCTURAL GENE FOR OROTIDYLIC ACID PYROPHOSPHORYLASE IN ESCHERICHIA COLI. J Mol Biol. 1964 May; 8:771.
-
PARDEE AB. CELL DIVISION AND A HYPOTHESIS OF CANCER. Natl Cancer Inst Monogr. 1964 May; 14:7-20.
-
Masters M, Kuempel PL, Pardee AB. Enzyme synthesis in synchronous cultures of bacteria. Biochem Biophys Res Commun. 1964 Feb 18; 15(1):38-42.
-
PARDEE AB, PRESTIDGE LS. INACTIVATION OF BETA-GALACTOSIDASE INDUCTION BY ULTRAVIOLET LIGHT. Biochim Biophys Acta. 1963 Dec 20; 76:614-21.
-
KADISH LJ, PARDEE AB. ON THE INTERNAL PH VALUE OF BACTERIA. Biochim Biophys Acta. 1963 Dec 13; 78:764-6.
-
KUEMPEL PL, PARDEE AB. THE CYCLE OF BACTERIAL DUPLICATION. J Cell Physiol. 1963 Oct; 62:SUPPL1:15-30.
-
PARDEE AB, WILSON AC. CONTROL OF ENZYME ACTIVITY IN HIGHER ANIMALS. Cancer Res. 1963 Sep; 23:1483-90.
-
RACHMELER M, PARDEE AB. Loss of viability and beta-galactosidase-forming ability as a consequence of tritium decay in Escherichia coli. Biochim Biophys Acta. 1963 Jan 29; 68:62-7.
-
BECKWITH JR, PARDEE AB, AUSTRIAN R, JACOB F. Coordination of the synthesis of the enzymes in the pyrimidine pathway of E. coli. J Mol Biol. 1962 Dec; 5:618-34.
-
PARDEE AB, BECKWITH JR. Genetic determination of constitutive enzyme levels. Biochim Biophys Acta. 1962 Jul 2; 60:452-4.
-
RILEY M, PARDEE AB. beta-Galactosidase formation following decay of 32P in Escherichia coli zygotes. J Mol Biol. 1962 Jul; 5:63-75.
-
WILSON AC, PARDEE AB. Regulation of flavin synthesis by Escherichia coli. J Gen Microbiol. 1962 Jun; 28:283-303.
-
RILEY M, PARDEE AB. Nutritional effects on frequencies of bacterial recombination. J Bacteriol. 1962 Jun; 83:1332-5.
-
GERHART JC, PARDEE AB. The enzymology of control by feedback inhibition. J Biol Chem. 1962 Mar; 237:891-6.
-
MASTERS M, PARDEE AB. Failure of ultraviolet-irradiated Escherichia coli to produce a cross-reacting protein. Biochim Biophys Acta. 1962 Jan 29; 56:609-11.
-
RILEY M, PARDEE AB. Gene expression: its specificity and regulation. Annu Rev Microbiol. 1962; 16:1-34.
-
PARDEE AB, PRESTIDGE LS. The initial kinetics of enzyme induction. Biochim Biophys Acta. 1961 Apr 29; 49:77-88.
-
RUSHIZKY GW, RILEY M, PRESTIDGE LS, PARDEE AB. Inactivation of enzyme formation by ultraviolet light. I. Action spectra and size of the sensitive unit. Biochim Biophys Acta. 1960 Dec 4; 45:70-6.
-
LITMAN RM, PARDEE AB. The induction of mutants of bacteriophage T2 by 5-bromouracil. IV. Kinetics of bromouracil-induced mutagenesis. Biochim Biophys Acta. 1960 Jul 29; 42:131-40.
-
LITMAN RM, PARDEE AB. The induction of mutants of bacteriophage T2 by 5-bromouracil. III. Nutritional and structural evidence regarding mutagenic action. Biochim Biophys Acta. 1960 Jul 29; 42:117-30.
-
PARDEE AB, PRESTIDGE LS. A requirement for pyrimidines in the first few minutes of T2 bacteriophage development. Biochim Biophys Acta. 1960 Jan 29; 37:544-6.
-
PARDEE AB, PRESTIDGE LS. On the nature of the repressor of beta-galactosidase synthesis in Escherichia coli. Biochim Biophys Acta. 1959 Dec; 36:545-7.
-
LITMAN RM, PARDEE AB. Mutations of bacteriophage T2 induced by bromouracil in the presence of chloramphenicol. Virology. 1959 May; 8(1):125-7.
-
PARDEE AB. Experiments on the transfer of information from DNA to enzymes. Exp Cell Res. 1959; Suppl 6:142-51.
-
WORMSER EH, PARDEE AB. Regulation of threonine biosynthesis in Escherichia coli. Arch Biochem Biophys. 1958 Dec; 78(2):416-32.
-
PARDEE AB, JACOB F, MONOD J. [The role of the inducible alleles and the constrtutive alleles in the synthesis of beta-galactosidase in zygotes of Escherichia coli]. C R Hebd Seances Acad Sci. 1958 May 28; 246(21):3125-8.
-
PARDEE AB, PRESTIDGE LS. Production of surplus DNA in E. coli, and its effects on bacterial syntheses. Biochim Biophys Acta. 1958 Feb; 27(2):412-3.
-
McFALL E, PARDEE AB, STENT GS. Effects of radiophosphorus decay on some synthetic capacities of bacteria. Biochim Biophys Acta. 1958 Feb; 27(2):282-97.
-
PARDEE AB, PRESTIDGE LS. Effects of azatryptophan on bacterial enzymes and bacteriophage. Biochim Biophys Acta. 1958 Feb; 27(2):330-44.
-
TRUCCO RE, PARDEE AB. Synthesis of Escherichia coli cell walls in the presence of penicillin. J Biol Chem. 1958 Jan; 230(1):435-46.
-
YATES RA, PARDEE AB. Control by uracil of formation of enzymes required for orotate synthesis. J Biol Chem. 1957 Aug; 227(2):677-92.
-
PRESTIDGE LS, PARDEE AB. Induction of bacterial lysis by penicillin. J Bacteriol. 1957 Jul; 74(1):48-59.
-
PARDEE AB. An inducible mechanism for accumulation of melibiose in Escherichia coli. J Bacteriol. 1957 Mar; 73(3):376-85.
-
WORMSER EH, PARDEE AB. Deoxyribonuclease activity in Escherichia coli K12 (lambda) after bacteriophage induction with ultraviolet irradiation. Virology. 1957 Feb; 3(1):76-83.
-
PARDEE AB, PAIGEN K, PRESTIDGE LS. A study of the ribonucleic acid of normal and chloromycetin-inhibited bacteria by zone electrophoresis. Biochim Biophys Acta. 1957 Jan; 23(1):162-73.
-
LITMAN RM, PARDEE AB. Production of bacteriophage mutants by a disturbance of deoxyribonucleic acid metabolism. Nature. 1956 Sep 8; 178(4532):529-31.
-
PARDEE AB, YATES RA. Control of pyrimidine biosynthesis in Escherichia coli by a feed-back mechanism. J Biol Chem. 1956 Aug; 221(2):757-70.
-
PARDEE AB, YATES RA. Pyrimidine biosynthesis in Escherichia coli. J Biol Chem. 1956 Aug; 221(2):743-56.
-
PARDEE AB, PRESTIDGE LS, SHORE VG. Incorporation of azatryptophan into proteins of bacteria and bacteriophage. Biochim Biophys Acta. 1956 Aug; 21(2):406-7.
-
PARDEE AB, PRESTIDGE LS. The dependence of nucleic acid synthesis on the presence of amino acids in Escherichia coli. J Bacteriol. 1956 Jun; 71(6):677-83.
-
SHORE VG, PARDEE AB. Energy transfer in conjugated proteins and nucleic acids. Arch Biochem Biophys. 1956 Jun; 62(2):355-68.
-
Pardee AB. High-School Students as Laboratory Assistants. Science. 1956 Apr 27; 123(3200):725.
-
KUNKEE RE, PARDEE AB. Studies on the role of deoxyribonuclease in T2 bacteriophage development. Biochim Biophys Acta. 1956 Feb; 19(2):236-46.
-
SHORE VG, PARDEE AB. Fluorescence of some proteins, nucleic acids and related compounds. Arch Biochem Biophys. 1956 Jan; 60(1):100-7.
-
PARDEE AB, PRESTIDGE LS. Induced formation of serine and threonine deaminases by Escherichia coli. J Bacteriol. 1955 Dec; 70(6):667-74.
-
PARDEE AB. Effect of energy supply on enzyme induction by pyrimidine requiring mutants of Escherichia coli. J Bacteriol. 1955 Mar; 69(3):233-9.
-
Pardee AB. NUCLEIC ACID PRECURSORS AND PROTEIN SYNTHESIS. Proc Natl Acad Sci U S A. 1954 May; 40(5):263-70.
-
PARDEE AB, WILLIAMS I. Enzymatic activity and bacteriophage infection. III. Increase of desoxyribonuclease. Ann Inst Pasteur (Paris). 1953 Jan; 84(1):147-56.
-
SCHWIMMER S, PARDEE AB. Principles and procedures in the isolation of enzymes. Adv Enzymol Relat Subj Biochem. 1953; 14:375-409.
-
PARDEE AB, KUNKEE RE. Enzyme activity and bacteriophage infection. II. Activities before and after virus infection. J Biol Chem. 1952 Nov; 199(1):9-24.
-
PARDEE AB, SCHWERDT CE. A simplified method of determining the sizes of viruses in impure preparations. Arch Biochem Biophys. 1952 Oct; 40(2):381-9.
-
PARDEE AB, WILLIAMS I. The increase in desoxyribonuclease of virus-infected E. coli. Arch Biochem Biophys. 1952 Sep; 40(1):222-3.
-
SCHWERDT CE, PARDEE AB. The intracellular distribution of Lansing poliomyelitis virus in the central nervous system of infected cotton rats. J Exp Med. 1952 Aug; 96(2):121-36.
-
SCHACHMAN HK, PARDEE AB, STANIER RY. Studies on the macro-molecular organization of microbial cells. Arch Biochem Biophys. 1952 Jul; 38:245-60.
-
PARDEE AB, SCHACHMAN HK, STANIER RY. Chromatophores of Rhodospirillum rubrum. Nature. 1952 Feb 16; 169(4294):282-3.
-
PARDEE AB, BLAKER RH. Size and shape of blood group A-substance. Proc Soc Exp Biol Med. 1951 Nov; 78(2):589-90.
-
PARDEE AB. Calculations on paper chromatography of peptides. J Biol Chem. 1951 Jun; 190(2):757-62.
-
PARDEE AB. Enzyme activity and bacteriophage infection. I. Breakdown of adenosinetriphosphate. J Gen Physiol. 1951 May; 34(5):619-26.
-
PARDEE AB, HEIDELBERGER C, POTTER VR. The oxidation of acetate-1-C14 by rat tissue in vitro. J Biol Chem. 1950 Oct; 186(2):625-35.
-
PARDEE AB, POTTER VR. Factors affecting the maintenance of oxidative phosphorylation in a kidney homogenate system. J Biol Chem. 1949 Dec; 181(2):739-53.
-
PARDEE AB. Measurement of oxygen uptake under controlled pressures of carbon dioxide. J Biol Chem. 1949 Jul; 179(3):1085-91.
-
PARDEE AB, POTTER VR. Malonate inhibition of oxidations in the Krebs tricarboxylic acid cycle. J Biol Chem. 1949 Mar; 178(1):241-50.
-
PARDEE AB, PAULING L. The reaction of simple antigens with purified antibody. J Am Chem Soc. 1949 Jan; 71(1):143-8.
-
PARDEE AB, SWINGLE SM. The degree of association of some simple antigens. J Am Chem Soc. 1949 Jan; 71(1):148-50.
-
PARDEE AB, POTTER VR. Inhibition of succinic dehydrogenase by oxalacetate. J Biol Chem. 1948 Dec; 176(3):1085-94.
-
POTTER VR, PARDEE AB, LYLE GG. The assay of animal tissues for respiratory enzymes; conditions for oxalacetate oxidation in whole homogenates. J Biol Chem. 1948 Dec; 176(3):1075-84.
-
CAMPBELL DH, BLAKER RH, PARDEE AB. The purification and properties of antibody against p-azophenylarsonic acid and molecular weight studies from light scattering data. J Am Chem Soc. 1948 Jul; 70(7):2496-9.